Connection
Thomas Henthorn to Drug Administration Schedule
This is a "connection" page, showing publications Thomas Henthorn has written about Drug Administration Schedule.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.075 |
|
|
|
-
Henthorn TK. The effect of altered physiological states on intravenous anesthetics. Handb Exp Pharmacol. 2008; (182):363-77.
Score: 0.060
-
Troiani T, Serkova NJ, Gustafson DL, Henthorn TK, Lockerbie O, Merz A, Long M, Morrow M, Ciardiello F, Eckhardt SG. Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft model. Clin Cancer Res. 2007 Nov 01; 13(21):6450-8.
Score: 0.015